IDEAYA Biosciences, Inc.: capex

Value{"amount": 3857000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2024-01-01 – 2024-12-31
Statuscurrent
EntityIDEAYA Biosciences, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-25-022183 · Open the official SEC filing →
Retrieved: 2026-08-19T17:12:28.421159+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001676725/capex/2024-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/cfd64489-1ebd-4190-a45c-504dd8e02107

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies